NO20054472L - 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen - Google Patents

2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen

Info

Publication number
NO20054472L
NO20054472L NO20054472A NO20054472A NO20054472L NO 20054472 L NO20054472 L NO 20054472L NO 20054472 A NO20054472 A NO 20054472A NO 20054472 A NO20054472 A NO 20054472A NO 20054472 L NO20054472 L NO 20054472L
Authority
NO
Norway
Prior art keywords
sulfonylamino
benzamide
pyridin
methoxy
propyl
Prior art date
Application number
NO20054472A
Other languages
English (en)
Norwegian (no)
Inventor
Klaus Wirth
Joachim Brendel
Heinz Goegelein
Gert Ulrich Kuerzel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20054472L publication Critical patent/NO20054472L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20054472A 2003-03-18 2005-09-27 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen NO20054472L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10312073A DE10312073A1 (de) 2003-03-18 2003-03-18 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen
PCT/EP2004/002247 WO2004083157A1 (de) 2003-03-18 2004-03-05 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
NO20054472L true NO20054472L (no) 2005-09-27

Family

ID=32920928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054472A NO20054472L (no) 2003-03-18 2005-09-27 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen

Country Status (22)

Country Link
EP (1) EP1606237A1 (xx)
JP (1) JP2006520343A (xx)
KR (1) KR20050110681A (xx)
CN (1) CN100361943C (xx)
AR (1) AR043622A1 (xx)
AU (1) AU2004222137A1 (xx)
BR (1) BRPI0408441A (xx)
CA (1) CA2519022A1 (xx)
DE (1) DE10312073A1 (xx)
HK (1) HK1086819A1 (xx)
HR (1) HRP20050815A2 (xx)
MA (1) MA27749A1 (xx)
MX (1) MXPA05009763A (xx)
MY (1) MY176510A (xx)
NO (1) NO20054472L (xx)
NZ (1) NZ542476A (xx)
PE (1) PE20050307A1 (xx)
RS (1) RS20050690A (xx)
RU (1) RU2333202C2 (xx)
TW (1) TW200500342A (xx)
WO (1) WO2004083157A1 (xx)
ZA (1) ZA200506328B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009931A1 (de) * 2004-02-26 2005-09-15 Aventis Pharma Deutschland Gmbh Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
DE102005028845A1 (de) * 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US8278317B2 (en) * 2005-07-22 2012-10-02 Merck Sharp & Dohme Corp. Potassium channel inhibitors
CA2761639C (en) * 2009-05-29 2016-06-07 Raqualia Pharma Inc. Aryl substituted carboxamide derivatives as calcium or sodium channel blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
CN1756728A (zh) 2006-04-05
HK1086819A1 (en) 2006-09-29
BRPI0408441A (pt) 2006-04-04
PE20050307A1 (es) 2005-06-08
WO2004083157A1 (de) 2004-09-30
MY176510A (en) 2020-08-12
ZA200506328B (en) 2006-04-26
CA2519022A1 (en) 2004-09-30
MXPA05009763A (es) 2006-01-27
RS20050690A (sr) 2008-04-04
JP2006520343A (ja) 2006-09-07
AR043622A1 (es) 2005-08-03
KR20050110681A (ko) 2005-11-23
AU2004222137A1 (en) 2004-09-30
CN100361943C (zh) 2008-01-16
EP1606237A1 (de) 2005-12-21
RU2005132163A (ru) 2006-04-10
DE10312073A1 (de) 2004-09-30
HRP20050815A2 (en) 2006-09-30
RU2333202C2 (ru) 2008-09-10
NZ542476A (en) 2008-05-30
MA27749A1 (fr) 2006-02-01
TW200500342A (en) 2005-01-01

Similar Documents

Publication Publication Date Title
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
NO20051036L (no) 3,4-disubstituerte syklobuten-1,2-dioner som CXC-kjemokinreseptorligander
NO950297L (no) Prolinamidderivater
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
HK1048989A1 (en) Heterocyclic derivatives and pharmaceutical use thereof.
DK1263722T3 (da) Farmaceutiske sammensætninger, som indeholder azetidinderivat, nye azetidinderivater og fremstilling deraf
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
WO2001064642A3 (en) Benzamides and related inhibitors of factor xa
NO20052182L (no) Nye forbindelser
CA2296604A1 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
NO20044501L (no) [1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler
DK1447399T3 (da) 2-oxo-1-pyrrolidinderivat og dets farmaceutiske anvendelser
NO20054472L (no) 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen
NO20040881L (no) Orale antidiabetes midler.
GEP20053505B (en) Diphenyl Ether Compounds Useful in Therapy
NO20044091L (no) Anvendelse av substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on for fremstilling av medikamenter som inhiberer pankreatisk lipase
NO20013601L (no) Nye morfolinobenzamidsalter
IL149306A0 (en) Benzamidine derivatives and pharmaceutical compositions containing the same
ES2147499A1 (es) Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos.
NO180534C (no) Nonatetraensyrederivat, farmasöytisk preparat inneholdende dette, og anvendelser av derivatet
HK1083839A1 (en) Indoline compound and medicinal use thereof
AU5233896A (en) Use of (alpha-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reuptake and new compounds for this use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application